A nxiety disorders are among the most prevalent of all the mental disorders (1, 2) . Many people who suffer from anxiety disorders choose not to seek treatment or present to health professionals for complaints that are often not recognized as being caused by anxiety (3) . Although they have been considered mild and transient, most anxiety disorders are chronic with very low natural remission rates. Despite this history, relatively brief treatment involving few sessions can often make a considerable difference to the immediate symptoms, disability, and long-term outcome (4) . It has become clear that the successful treatment of anxiety disorders is dependent on accurate diagnosis and assessment, particularly when cognitive behavioural treatments are part of the disorder's management.
The series of papers about anxiety disorders that have appeared in the last few editions of The Canadian Journal of Psychiatry has addressed some of the areas in anxiety disorders research and practice that have received little attention. The papers by Dr Tim Brown and Dr Martin Antony in the October issue focused on the specific nature of the disorders so patients with these problems might be recognized more frequently and earlier in the course of their illness. The paper by Dr Gail Steketee in the November issue detailed the large burden of care carried by the families of people with obsessive-compulsive disorder (OCD). In this issue, Dr Isaac Marks has summarized much of the recent data that has become available about the effects of cognitive-based and exposure-based treatments on OCD.
One of the difficulties in recognizing and managing anxiety disorders is that they are frequently comorbid with other anxiety disorders or with mood or substance use disorders, and it is the anxiety disorder that is often overlooked when another disorder is also present. The tendency is to address the most obvious problem initially. The anxiety disorders share much of their symptomatology with each other and with other mood syndromes, and this may lead clinicians to overdiagnose some syndromes at the expense of underdiagnosing some of the less well-recognized syndromes. So, for example, the presentation of panic attacks may lead to a presumptive diagnosis of panic disorder (PD) unless a careful interview reveals that the panic attacks are limited to particular situations. Similarly, the presence of chronic worry and tension may lead to a diagnosis of generalized anxiety disorder unless follow-up questions establish the focus of the worry, which may then lead to a revised diagnosis of, for example, OCD or hypochondriasis. The recent epidemiological data regarding the frequency of occurrence of social phobia and OCD in the community have called into question the validity of the methods used in the community studies and cast doubt on the accurate prevalence of the specific anxiety disorders (5, 6) .
Generalized anxiety disorder (GAD) has been shown to have a general population lifetime prevalence of about 5% (1). This observed common occurrence contrasts markedly with the relative rarity of GAD, in its pure form, in specialized anxiety disorder treatment clinics. The definition of GAD has changed considerably throughout the various versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM). In the DSM-III, GAD was regarded as a brief, nonspecific, residual condition to be diagnosed hierarchically after the other anxiety disorders. In that form, GAD was not clearly separate from anxiety states triggered by environmental events. Much of the treatment literature of the early to mid-1980s related to outcome in GAD is of limited value because we cannot be certain which conditions were included in the treatment samples (7) . In the DSM-III-R, GAD became a more restricted category with positive diagnostic features, and in the DSM-IV, the criteria were again focused. Currently the nature of GAD and its origins in "anxious apprehension" are being actively investigated, and the appropriate psychological treatments are being clarified and tested (8) . Dr Brown's paper addresses these issues and draws particular attention to the psychological underpinnings of chronic worry.
Social phobia has begun to receive an increasing amount of attention in the past few years. Two books about this topic were published for professionals in 1995, and an overview for the lay public was published in 1994 (9) (10) (11) . Despite the increase in attention, however, social phobia is quite commonly missed as a primary condition or as a comorbid diagnosis. In part, this is probably due to the very nature of social phobia, in which people with the condition are ashamed of their feelings and of how they present themselves. They are unlikely to describe their difficulties unless they perceive that it is safe to do so. Clinicians dealing with populations at high risk for social phobia, such as adolescents, depressed people, those with substance use problems, and those with other anxiety disorders, need to stay alert to the possibility that the condition will only be revealed if the patient is directly asked about it.
OCD has changed from being a rarely recognized disorder to one that is well recognized and for which we fortunately have effective psychological and pharmacological treatments (12, 13) . OCD is a disorder that can be very persistent and very disruptive to the life of a family in which one or more member suffers from the disorder. The role of the family in treatment can be of great importance and assist the generalization of treatment gains to the patient's usual surroundings. Developments in the psychological treatment of OCD have centred on the additional effectiveness of cognitive interventions when combined with the now standard exposure-based therapies and on how to make therapy more accessible.
The evidence-based literature shows that the treatments for anxiety disorders which have been demonstrated to be effective are mainly those based on cognitive behavioural principles and the antidepressants, particularly the selective serotonin reuptake inhibitors (SSRIs). Little is known about predictors of outcome, how to choose specific treatment for a particular person, the effect of the order of therapies, or the long-term outcome of treatment. These are all areas in which research is necessary to allow us to help our patients more effectively than we can at present.
